In the article “Nanochon Raises $4.1M to Advance Cartilage Repair Innovation into First-in-Human Clinical Study,” BioBuzz news reports that U.S.-based medical device startup Nanochon, co-founded by GW Engineering alumnus Ben Holmes, Ph.D. ‘16, has raised $4.1 million in Seed Prime II financing. This funding will support Nanochon’s first human clinical trial of its 3D printed knee implant.
Here is an excerpt from the article: “Leadership sees the current raise as a validation not only of the technology, but of the broader execution plan. Chief executive officer and co-founder Ben Holmes emphasized that investor support extends beyond capital, pointing to strategic input around regulatory planning, commercialization, and long-term scale as Nanochon enters its clinical phase.”
Read the full article on BioBuzz News. For more coverage, check out the Washington Business Journal, Finsmes, PR Newswire, Pulse 2.0, 29 News, WDBJ7, and 3Dprint.com.
In a follow-up article, "Nanochon targeting $20m Series A funding round after strong start to 2026," Voxel Matters details Holmes' next steps for Nanochon to build on the $11.3m in funding it has received to date and help it secure FDA approval for its implant.
Here is an excerpt from the article: “Not only do we have strong financial backing, but these partners also offer us support in commercial and regulatory strategies as well. As we step up to the start line of our clinical journey, Nanochon is powered by an exceptional team whose dedication, creativity, and execution make this moment possible. With the right people, partners, and capital in place, we’re excited to translate years of innovation into meaningful outcomes for patients," said Holmes.
Read the full article on Voxel Matters.